SYRA (Syra Health) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 08, 2026)


SYRA Syra Health Corp SYRA
12 GF Score
Price $0.71
GF Value $0.23
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Syra Health Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Syra Health's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

SYRA vs NIVF, BICX, HLYK: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Care Facilities subindustry, Syra Health's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syra Health Margin of Safety % (DCF Earnings Based) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Syra Health's Margin of Safety % (DCF Earnings Based) falls into.


SYRA
12GF Score
Syra Health Corp SYRA
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Syra Health (SYRA) Overvalued in 2026?

Based on GuruFocus' analysis, Syra Health stock appears to be overvalued. The current stock price of $0.71 is trading 207.7% above its estimated GF Value™ of $0.23. GuruFocus considers Syra Health to be Significantly Overvalued.

Key valuation signals for SYRA:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $0.23 vs. price of $0.71 (207.7% above fair value)
  • GF Score™: 12/100 with 5 warning signs

No single metric tells the full story. See the SYRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syra Health Business Description

Address 1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032
Syra Health Corp is an integrated healthcare solutions company serving government and commercial healthcare organizations. It delivers end-to-end capabilities across population health, behavioral and mental health, digital health, health education and training, and healthcare workforce development and staffing. The various services offered by the company include Syrenity, a mental health application providing preventative care and interventions for behavioral and mental health conditions; SyraBot, a chatbot offering members access to necessary information via the firm's AI-powered customer support chat system; CarePlus, an electronic medical records solution designed for small to mid-sized healthcare organizations; and patient engagement and education services, among others.
12GF Score

Get the complete analysis for SYRA

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price
$0.23
GF Value